The Biomarker Multiplexing Capabilities Of LC-MS Technology
Metabolomic Diagnostics is delighted to announce that CEO Robin Tuytten will present "The Biomarker Multiplexing Capabilities Of LC-MS Technology: The Key to Unlock Personalised Preeclampsia Risk Prediction Early in Pregnancy" for the American Association for Clinical Chemistry (AACC) on Jan 27th 2021. AACC is a global [...]